pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
ASTRAZENECA · news · pharmadog
← back to ASTRAZENECA
News mentioning ASTRAZENECA
209
stories
Jun 9, 26
STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
stat
Jun 8, 26
Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
stat
Jun 8, 26
#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six months
endpoints
Jun 8, 26
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
stat
Jun 8, 26
Tango data add to growing momentum for pancreatic cancer drugs
biopharma dive
Jun 4, 26
A Spanish biotech banks $87M to make differentiated ADCs
biopharma dive
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 1, 26
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
stat
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
CDC says containing the spread of Ebola is top priority
stat
Jun 1, 26
#ASCO26: AstraZeneca's triplet combo succeeds in liver cancer subgroup
endpoints
May 29, 26
At ASCO, Merck makes case for a ‘cornerstone’ cancer drug
biopharma dive
May 29, 26
AstraZeneca seeks path for failed antibody; Imfinzi, Tremfya get label expansions
endpoints
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
Pfizer, Innovent strike $10B cancer drug deal
biopharma dive
May 27, 26
AstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Wave
endpoints
May 19, 26
STAT+: Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case
stat
May 19, 26
STAT+: A new ranking of pharma companies by R&D performance
stat
May 19, 26
STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
stat
May 18, 26
STAT+: Maryland state affordability board places a price cap on Ozempic
stat
May 18, 26
With no approved vaccine for Ebola outbreak, experts weigh testing a long shot
stat
May 18, 26
STAT+: Trump’s CMS to allow skimpier plans on ACA exchanges
stat
May 18, 26
STAT+: Why the WakeMed – Atrium Health hospital merger matters
stat
May 18, 26
STAT+: AstraZeneca picks up FDA approval for hypertension drug
stat
May 18, 26
FDA approves AstraZeneca’s new kind of hypertension drug
biopharma dive
May 18, 26
Merck ADC, licensed from China, hits mark in first big global trial
biopharma dive
May 18, 26
STAT+: Supreme Court rejects challenge to Medicare drug price negotiation
stat
May 18, 26
The Supreme Court won't take up drugmakers' IRA cases
endpoints
May 18, 26
FDA approves AstraZeneca’s baxdrostat for certain patients with hypertension
endpoints
← prev
page 6 of 7
next →
